ChromaDex to Present at the Lytham Partners Spring 2023 Investor Conference

Author's Avatar
May 11, 2023

ChromaDex Corp. (NASDAQ:CDXC), a global bioscience company dedicated to healthy aging, today announced that its Chief Executive Officer, Rob Fried, and Chief Financial Officer, Brianna Gerber, will be participating in the Lytham Partners Spring 2023 Investor Conference.